LinkOPH

SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, to…

Read more →

Doheny Eye Institute has selected SriniVas Sadda, MD, as president and chief scientific officer, according to a press release.“When we embarked on the task of choosing a new president and CSO, our goal was to keep Doheny on the path of global leadership in basic and clinical vision research and advanced patient care,” Ed Landry, chairman of the Doheny board of directors, said in the release. “We are thrilled that Dr. Sadda has agreed to serve in this vitally important role for Doheny and are confident that he will continue (Read more...)

NovaBay Pharmaceuticals reported increases in product revenue and gross profit in the first quarter 2015 due to the commercialization of Avenova, according to a press release.Product revenue increased to $492,000 from $188,000 in the first quarter 2014…

Read more →

Cataracts develop more frequently and at an earlier age in patients with diabetes, according to clinical and epidemiological studies. With the rapid increase of both type 1 and type 2 diabetes worldwide, the number of cataract surgeries in diabetic pat…

Read more →

KIAWAH ISLAND, S.C. — At the Kiawah Eye 2015 meeting here, Justin Roman, MD, discusses an evaluation method developed at Storm Eye Institute, where he is an ophthalmology resident, using SD-OCT and epithelium mapping to differentiate keratoconic eyes from normal eyes and severity of keratoconus.

Read more →